Annovis Bio, Inc. · NYSE:ANVS
Annovis Bio, Inc. shareholders
As of Sep 30, 2026, 58 institutions reported holding Annovis Bio, Inc., 11.8% of its shares. Largest: Vanguard, Marshall Wace, LLP and Two Sigma. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Annovis Bio, Inc. | Change | Filed |
|---|---|---|---|---|
| Vanguard | 1.82M | 2.9% | −18,927 | Nov 13, 2026 |
| Marshall Wace, LLP | 1.7M | 2.7% | −141K | Nov 13, 2026 |
| Two Sigma | 748K | 1.2% | +169K | Nov 16, 2026 |
| Renaissance Technologies | 736K | 1.2% | −266K | Nov 12, 2026 |
| Geode Capital | 324K | 0.52% | +40,605 | Nov 6, 2026 |
| BlackRock | 245K | 0.40% | −4,760 | Nov 13, 2026 |
| Susquehanna | 243K | 0.39% | +96,359 | Nov 16, 2026 |
| Gsa Capital Partners LLP | 218K | 0.35% | +168K | Nov 16, 2026 |
| Citadel | 212K | 0.34% | −31,790 | Nov 16, 2026 |
| Morgan Stanley | 199K | 0.32% | +199K | Nov 13, 2026 |